HRCT PATTERNS IN FIBROTIC INTERSTITIAL LUNG DISEASES: COMPARATIVE ANALYSIS OF IDIOPATHIC PULMONARY FIBROSIS, SARCOIDOSIS, HYPERSENSITIVITY PNEUMONITIS, AND CONNECTIVE TISSUE DISEASE–RELATED ILD
DOI:
https://doi.org/10.35120/medisij0403017nKeywords:
HRCT, idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, connective tissue disease, interstitial lung disease.Abstract
High-resolution computed tomography (HRCT) remains the cornerstone in the non-invasive evaluation of fibrotic interstitial lung diseases (ILDs), providing essential information for diagnostic classification and guiding clinical management. Despite well-established imaging criteria, many fibrotic ILDs share overlapping features that can complicate interpretation. This study aimed to evaluate and compare the HRCT patterns of idiopathic pulmonary fibrosis (IPF), sarcoidosis, fibrotic hypersensitivity pneumonitis (fHP), and connective tissue disease–associated ILD (CTD-ILD) in a single-center cohort, highlighting the distinguishing characteristics that aid in differential diagnosis. A total of 50 patients with multidisciplinary consensus diagnosis were retrospectively included: 15 with IPF, 12 with sarcoidosis, 13 with fHP, and 10 with CTD-ILD. All underwent volumetric inspiratory HRCT with collimation ≤1.5 mm. Image interpretation was performed by one experienced thoracic radiologist with over 10 years of subspecialty practice, who assessed the scans for zonal predominance, axial distribution, and fibrotic features including reticulation, honeycombing, traction bronchiectasis, ground-glass opacity, mosaic attenuation, and nodules. In the IPF group, fibrosis was predominantly basal and subpleural in 93% of cases, with honeycombing in 80% and traction bronchiectasis in 87%, while mosaic attenuation was rare. Sarcoidosis was characterized by upper- and mid-lung predominance in 75%, perilymphatic nodules in 83%, bronchial distortion in 58%, and less frequent honeycombing (25%). fHP showed diffuse or mid-lung fibrosis in 69% of patients, mosaic attenuation in 85%, lobular air-trapping in 77%, and centrilobular nodules in 54%. CTD-ILD was most often associated with peripheral or peribronchovascular fibrosis (60%), an NSIP-like pattern in 70%, ground-glass opacity in 65%, and traction bronchiectasis in 55%. Comparative analysis demonstrated statistically significant differences in zonal distribution and ancillary features among the four disease groups (p < 0.01). These findings reinforce the role of HRCT pattern recognition in narrowing the differential diagnosis of fibrotic ILD. Basal subpleural honeycombing should raise a high suspicion for IPF, while the presence of upper-lobe perilymphatic nodules is highly suggestive of sarcoidosis. The combination of mosaic attenuation, lobular air-trapping, and centrilobular nodules strongly favors fHP, whereas NSIP-like changes with peribronchovascular involvement are more typical for CTD-ILD. Integrating these imaging clues into clinical assessment may improve diagnostic accuracy, reduce the need for invasive procedures, and facilitate early, disease-specific management in patients with fibrotic ILD.
Downloads
References
Althobiani, M. A., Russell, A.-M., Jacob, J., Ranjan, Y., Folarin, A. A., Hurst, J. R., & Porter, J. C. (2024). Interstitial lung disease: A review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment. Frontiers in Medicine, 11, 1296890. https://doi.org/10.3389/fmed.2024.1296890
Cottin, V., Wollin, L., Fischer, A., Quaresma, M., Stowasser, S., & Harari, S. (2019). Fibrosing interstitial lung diseases: Knowns and unknowns. European Respiratory Review, 28(151), 180100. https://doi.org/10.1183/16000617.0100-2018
Gupta Brixey, A., Oh, A. S., Alsamarraie, A., & Chung, J. H. (2023). Pictorial review of fibrotic interstitial lung disease on high-resolution CT scan and updated classification. Chest, 164(3), 895–909. https://doi.org/10.1016/j.chest.2023.05.041
Larici, A. R., Biederer, J., Cicchetti, G., Franquet Casas, T., Screaton, N., Remy-Jardin, M., Parkar, A., Prosch, H., Schaefer-Prokop, C., Frauenfelder, T., Ghaye, B., & Sverzellati, N. (2025). ESR Essentials: Imaging in fibrotic lung diseases—Practice recommendations by the European Society of Thoracic Imaging. European Radiology, 35(3), 2245–2255. https://doi.org/10.1007/s00330-024-11054-2
Lederer, C., Storman, M., Tarnoki, A. D., Tarnoki, D. L., Margaritopoulos, G. A., & Prosch, H. (2024). Imaging in the diagnosis and management of fibrosing interstitial lung diseases. Breathe, 20(2), 240006. https://doi.org/10.1183/20734735.0006-2024
Łyżwa, E., Wakuliński, J., Szturmowicz, M., Tomkowski, W., & Sobiecka, M. (2025). Fibrotic pulmonary sarcoidosis—From pathogenesis to management. Journal of Clinical Medicine, 14(7), 2381. https://doi.org/10.3390/jcm14072381
Moor, C. C., Oppenheimer, J. C., Nakshbandi, G., Aerts, J. G. J. V., Brinkman, P., Maitland-van der Zee, A. H., &
Poerio, A. (2023). Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of ‘progressive pulmonary fibrosis’ using chest CT: A narrative review. Clinical and Experimental Medicine, 23(8), 2741–2756. https://doi.org/10.1007/s10238-023-01202-1
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., Flaherty, K. R., Wells, A., Martinez, F. J., Azuma, A., Bice, T. J., Bouros, D., Brown, K. K., Collard, H. R., Duggal, A., … Wilson, K. C. (2020). Diagnosis of hypersensitivity pneumonitis in adults: An official ATS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 202(3), e36–e69. https://doi.org/10.1164/rccm.202005-2032ST
Rodriguez, K., Ashby, C. L., Varela, V. R., & Sharma, A. (2022). High-resolution computed tomography of fibrotic interstitial lung disease. Seminars in Respiratory and Critical Care Medicine, 43(6), 764–779. https://doi.org/10.1055/s-0042-1755563
Shao, T., Shi, X., Yang, S., Zhang, W., Li, X., Shu, J., Alqalyoobi, S., Zeki, A. A., Leung, P. S., & Shuai, Z. (2021). Interstitial lung disease in connective tissue disease: A common lesion with heterogeneous mechanisms and treatment considerations. Frontiers in Immunology, 12, 684699. https://doi.org/10.3389/fimmu.2021.684699
Sverzellati, N., Lynch, D. A., Hansell, D. M., Johkoh, T., King, T. E., & Travis, W. D. (2015). American Thoracic Society–European Respiratory Society classification of the idiopathic interstitial pneumonias: Advances in knowledge since 2002. RadioGraphics, 35(7), 1849–1872. https://doi.org/10.1148/rg.2015140334
Torres, P. P. T. S., Rabahi, M. F., Moreira, M. A. C., Escuissato, D. L., Meirelles, G. S. P., & Marchiori, E. (2021). Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases. Jornal Brasileiro de Pneumologia, 47(3), e20200096. https://doi.org/10.36416/1806-3756/e20200096
Wijsenbeek, M. S. (2020). Exhaled breath analysis by use of eNose technology: A novel diagnostic tool for interstitial lung disease. European Respiratory Journal. Advance online publication. https://doi.org/10.1183/13993003.00574-2020
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.